At the beginning of her 12-year marriage, Dahlia, 33, couldn’t get enough of her husband.

“We were constantly having sex,” she says. “The desire was so great. It was wonderful. I was always the initiator. And we had great sex, every time.”

But a few years ago her desire just shut off like a spigot.

“I just have no interest in it anymore. I realized recently I could probably go a whole year without sex and probably be just fine,” says the receptionist and mother of three.

Her lack of interest in sex has caused a huge rift in her relationship. If there was a pill she could pop to turn her on again — and save her marriage — Dahlia says she would take it in a heartbeat.

She may be in luck.

On June 18, German pharmaceutical company Boehringer Ingelheim will present the first “female Viagra” pill to the Food and Drug Administration, which will vote on the pill’s safety and efficacy. If approved, the unsexily named “flibanserin” could be on the market by year’s end.

The prescription pill supposedly boosts sexual desire in women ages 18 to 50 who say they suffer from hypoactive sexual desire disorder — or low libido — and works by playing with neurotransmitters in the brain, much like antidepressants.

Whether or not it gets approved, the pill is already causing convulsions among New York women.

“If all these men weren’t so pumped up on Viagra, women wouldn’t need to be so pumped up, too,” says Lesley Jane Seymour, editor-in-chief of More magazine, which caters to women 40 and up.

“Do we need a drug or do we need men to maybe try a little harder in bed? It’s like — ‘Now you guys have your Viagra, so figure out how to turn me on again, babe!’”

Although flibanserin is being called female Viagra, it works differently from the little blue pill. Traditional Viagra simply increases the blood flow to the male genitalia; it has nothing to do with the trickier psychological origins of desire. Flibanserin, on the other hand, blocks serotonin in the brain, which can inhibit sexual function, says Dr. Anita Clayton of the University of Virginia, who led studies of the pill in the US.

Read more: http://www.nypost.com/p/entertainment/would_you_take_female_viagra_fhC9jsDIA6EZqyS6F98kdP#ixzz0p9qW1heI